Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kassiou

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
European Journal of Pharmacology|June 30, 2001
Trishomocubanes: novel sigma-receptor ligands modulate amphetamine-stimulated [3H]dopamine releaseX Liu, S Nuwayhid, M J Christie, et al.
Physics in Medicine and Biology|April 3, 2010
Attenuation correction for the large non-human primate brain imaging using microPETS Naidoo-Variawa, W Lehnert, M Kassiou, et al.
Nuclear Medicine and Biology|November 1, 2000
The influence of tomograph sensitivity on kinetic parameter estimation in positron emission tomography imaging studies of the rat brainS R Meikle, S Eberl, R R Fulton, et al.
Brain Research Bulletin|November 15, 2008
Behavioural effects of a selective NMDA NR1A/2B receptor antagonist in rats with unilateral 6-OHDA+parafascicular lesionsL Truong, H N Allbutt, M J Coster, et al.
Life Sciences|January 1, 1995
[3H]A-69024: a non-benzazepine ligand for in vitro and in vivo studies of dopamine D1 receptorsM Kassiou, U A Scheffel, J L Musachio, et al.
Clinical and Experimental Pharmacology & Physiology|September 13, 2008
Neuroprotective effects of a selective N-methyl-D-aspartate NR2B receptor antagonist in the 6-hydroxydopamine rat model of Parkinson's diseaseK R Leaver, H N Allbutt, N J Creber, et al.
Current Medicinal Chemistry|October 14, 2010
Insights into structure-activity relationships and CNS therapeutic applications of NR2B selective antagonistsC Beinat, S Banister, I Moussa, et al.
British Journal of Pharmacology|March 20, 2014
Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non-peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in ratsC Hicks, L Ramos, T Reekie, et al.
Medchemcomm|August 16, 2018
Ring-opened aminothienopyridazines as novel tau aggregation inhibitorsM Moir, S W Chua, T Reekie, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|November 16, 2002
Preparation of a bromine-76 labelled analogue of epibatidine: a potent ligand for nicotinic acetylcholine receptor studiesM Kassiou, C Loc'h, F Dolle, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
European Journal of Pharmacology|June 30, 2001
Trishomocubanes: novel sigma-receptor ligands modulate amphetamine-stimulated [3H]dopamine releaseX Liu, S Nuwayhid, M J Christie, et al.
Physics in Medicine and Biology|April 3, 2010
Attenuation correction for the large non-human primate brain imaging using microPETS Naidoo-Variawa, W Lehnert, M Kassiou, et al.
Nuclear Medicine and Biology|November 1, 2000
The influence of tomograph sensitivity on kinetic parameter estimation in positron emission tomography imaging studies of the rat brainS R Meikle, S Eberl, R R Fulton, et al.
Brain Research Bulletin|November 15, 2008
Behavioural effects of a selective NMDA NR1A/2B receptor antagonist in rats with unilateral 6-OHDA+parafascicular lesionsL Truong, H N Allbutt, M J Coster, et al.
Life Sciences|January 1, 1995
[3H]A-69024: a non-benzazepine ligand for in vitro and in vivo studies of dopamine D1 receptorsM Kassiou, U A Scheffel, J L Musachio, et al.
Clinical and Experimental Pharmacology & Physiology|September 13, 2008
Neuroprotective effects of a selective N-methyl-D-aspartate NR2B receptor antagonist in the 6-hydroxydopamine rat model of Parkinson's diseaseK R Leaver, H N Allbutt, N J Creber, et al.
Current Medicinal Chemistry|October 14, 2010
Insights into structure-activity relationships and CNS therapeutic applications of NR2B selective antagonistsC Beinat, S Banister, I Moussa, et al.
British Journal of Pharmacology|March 20, 2014
Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non-peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in ratsC Hicks, L Ramos, T Reekie, et al.
Medchemcomm|August 16, 2018
Ring-opened aminothienopyridazines as novel tau aggregation inhibitorsM Moir, S W Chua, T Reekie, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|November 16, 2002
Preparation of a bromine-76 labelled analogue of epibatidine: a potent ligand for nicotinic acetylcholine receptor studiesM Kassiou, C Loc'h, F Dolle, et al.
Pageof 4